プレリキサフォルの世界市場 2020年

• 英文タイトル：Global Plerixafor Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114869 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、プレリキサフォルの世界市場を調査対象にし、プレリキサフォルの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（24MG/1.2ML、タイプII）、用途別分析（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：sanofi-aventis ・企業別売上、市場シェア ・プレリキサフォルの地域別市場分析 ・プレリキサフォルの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・プレリキサフォルのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・プレリキサフォルのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・プレリキサフォルの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・プレリキサフォルの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・プレリキサフォルの種類別市場規模2015-2020：24MG/1.2ML、タイプII ・プレリキサフォルの用途別市場規模2015-2020：非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者 ・プレリキサフォルの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Plerixafor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Plerixafor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Plerixafor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Plerixafor market has been segmented into:
24MG/1.2ML
Type II

By Application, Plerixafor has been segmented into:
Non-Hodgkin’s lymphoma (NHL) Patients
Multiple myeloma (MM) Patients

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Plerixafor market presented in the report. This section sheds light on the sales growth of different regional and country-level Plerixafor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Plerixafor market.

The report offers in-depth assessment of the growth and other aspects of the Plerixafor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Plerixafor Market Share Analysis
Plerixafor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Plerixafor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Plerixafor sales, revenue and market share for each player covered in this report.

The major players covered in Plerixafor are:
sanofi-aventis

レポート目次

---

1 Plerixafor Market Overview
1.1 Product Overview and Scope of Plerixafor
1.2 Classification of Plerixafor by Type
1.2.1 Global Plerixafor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Plerixafor Revenue Market Share by Type in 2019
1.2.3 24MG/1.2ML
1.2.4 Type II
1.3 Global Plerixafor Market by Application
1.3.1 Overview: Global Plerixafor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Non-Hodgkin’s lymphoma (NHL) Patients
1.3.3 Multiple myeloma (MM) Patients
1.4 Global Plerixafor Market by Regions
1.4.1 Global Plerixafor Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Plerixafor (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Plerixafor Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Plerixafor Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Plerixafor Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Plerixafor Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Plerixafor Status and Prospect (2015-2025)
2 Company Profiles
2.1 sanofi-aventis
2.1.1 sanofi-aventis Details
2.1.2 sanofi-aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 sanofi-aventis SWOT Analysis
2.1.4 sanofi-aventis Product and Services
2.1.5 sanofi-aventis Plerixafor Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Plerixafor Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Plerixafor Players Market Share
3.2.2 Top 10 Plerixafor Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Plerixafor Revenue and Market Share by Regions
4.2 North America Plerixafor Revenue and Growth Rate (2015-2020)
4.3 Europe Plerixafor Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Plerixafor Revenue and Growth Rate (2015-2020)
4.5 South America Plerixafor Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Plerixafor Revenue and Growth Rate (2015-2020)
5 North America Plerixafor Revenue by Countries
5.1 North America Plerixafor Revenue by Countries (2015-2020)
5.2 USA Plerixafor Revenue and Growth Rate (2015-2020)
5.3 Canada Plerixafor Revenue and Growth Rate (2015-2020)
5.4 Mexico Plerixafor Revenue and Growth Rate (2015-2020)
6 Europe Plerixafor Revenue by Countries
6.1 Europe Plerixafor Revenue by Countries (2015-2020)
6.2 Germany Plerixafor Revenue and Growth Rate (2015-2020)
6.3 UK Plerixafor Revenue and Growth Rate (2015-2020)
6.4 France Plerixafor Revenue and Growth Rate (2015-2020)
6.5 Russia Plerixafor Revenue and Growth Rate (2015-2020)
6.6 Italy Plerixafor Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Plerixafor Revenue by Countries
7.1 Asia-Pacific Plerixafor Revenue by Countries (2015-2020)
7.2 China Plerixafor Revenue and Growth Rate (2015-2020)
7.3 Japan Plerixafor Revenue and Growth Rate (2015-2020)
7.4 Korea Plerixafor Revenue and Growth Rate (2015-2020)
7.5 India Plerixafor Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Plerixafor Revenue and Growth Rate (2015-2020)
8 South America Plerixafor Revenue by Countries
8.1 South America Plerixafor Revenue by Countries (2015-2020)
8.2 Brazil Plerixafor Revenue and Growth Rate (2015-2020)
8.3 Argentina Plerixafor Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Plerixafor by Countries
9.1 Middle East & Africa Plerixafor Revenue by Countries (2015-2020)
9.2 Saudi Arabia Plerixafor Revenue and Growth Rate (2015-2020)
9.3 UAE Plerixafor Revenue and Growth Rate (2015-2020)
9.4 Egypt Plerixafor Revenue and Growth Rate (2015-2020)
9.5 South Africa Plerixafor Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Plerixafor Revenue and Market Share by Type (2015-2020)
10.2 Global Plerixafor Market Forecast by Type (2019-2024)
10.3 24MG/1.2ML Revenue Growth Rate (2015-2025)
10.4 Type II Revenue Growth Rate (2015-2025)
11 Global Plerixafor Market Segment by Application
11.1 Global Plerixafor Revenue Market Share by Application (2015-2020)
11.2 Plerixafor Market Forecast by Application (2019-2024)
11.3 Non-Hodgkin’s lymphoma (NHL) Patients Revenue Growth (2015-2020)
11.4 Multiple myeloma (MM) Patients Revenue Growth (2015-2020)
12 Global Plerixafor Market Size Forecast (2021-2025)
12.1 Global Plerixafor Market Size Forecast (2021-2025)
12.2 Global Plerixafor Market Forecast by Regions (2021-2025)
12.3 North America Plerixafor Revenue Market Forecast (2021-2025)
12.4 Europe Plerixafor Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Plerixafor Revenue Market Forecast (2021-2025)
12.6 South America Plerixafor Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Plerixafor Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Plerixafor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Plerixafor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Plerixafor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Plerixafor Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. sanofi-aventis Corporate Information, Location and Competitors
Table 6. sanofi-aventis Plerixafor Major Business
Table 7. sanofi-aventis Plerixafor Total Revenue (USD Million) (2017-2018)
Table 8. sanofi-aventis SWOT Analysis
Table 9. sanofi-aventis Plerixafor Product and Solutions
Table 10. sanofi-aventis Plerixafor Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Plerixafor Revenue (Million USD) by Players (2015-2020)
Table 12. Global Plerixafor Revenue Share by Players (2015-2020)
Table 13. Global Plerixafor Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Plerixafor Revenue Market Share by Regions (2015-2020)
Table 15. North America Plerixafor Revenue by Countries (2015-2020)
Table 16. North America Plerixafor Revenue Market Share by Countries (2015-2020)
Table 17. Europe Plerixafor Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Plerixafor Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Plerixafor Revenue by Countries (2015-2020)
Table 20. South America Plerixafor Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Plerixafor Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Plerixafor Revenue Market Share by Countries (2015-2020)
Table 23. Global Plerixafor Revenue (Million USD) by Type (2015-2020)
Table 24. Global Plerixafor Revenue Share by Type (2015-2020)
Table 25. Global Plerixafor Revenue Forecast by Type (2021-2025)
Table 26. Global Plerixafor Revenue by Application (2015-2020)
Table 27. Global Plerixafor Revenue Share by Application (2015-2020)
Table 28. Global Plerixafor Revenue Forecast by Application (2021-2025)
Table 29. Global Plerixafor Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Plerixafor Picture
Figure 2. Global Plerixafor Revenue Market Share by Type in 2019
Figure 3. 24MG/1.2ML Picture
Figure 4. Type II Picture
Figure 5. Plerixafor Revenue Market Share by Application in 2019
Figure 6. Non-Hodgkin's lymphoma (NHL) Patients Picture
Figure 7. Multiple myeloma (MM) Patients Picture
Figure 8. Global Plerixafor Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Plerixafor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Plerixafor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Plerixafor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Plerixafor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Plerixafor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Plerixafor Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Plerixafor Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Plerixafor Revenue Market Share in 2019
Figure 17. Global Top 10 Players Plerixafor Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Plerixafor Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Plerixafor Revenue Market Share by Regions (2015-2020)
Figure 21. Global Plerixafor Revenue Market Share by Regions in 2018
Figure 22. North America Plerixafor Revenue and Growth Rate (2015-2020)
Figure 23. Europe Plerixafor Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Plerixafor Revenue and Growth Rate (2015-2020)
Figure 25. South America Plerixafor Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Plerixafor Revenue and Growth Rate (2015-2020)
Figure 27. North America Plerixafor Revenue Market Share by Countries (2015-2020)
Figure 28. North America Plerixafor Revenue Market Share by Countries in 2019
Figure 29. USA Plerixafor Revenue and Growth Rate (2015-2020)
Figure 30. Canada Plerixafor Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Plerixafor Revenue and Growth Rate (2015-2020)
Figure 32. Europe Plerixafor Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Plerixafor Revenue Market Share by Countries in 2019
Figure 34. Germany Plerixafor Revenue and Growth Rate (2015-2020)
Figure 35. UK Plerixafor Revenue and Growth Rate (2015-2020)
Figure 36. France Plerixafor Revenue and Growth Rate (2015-2020)
Figure 37. Russia Plerixafor Revenue and Growth Rate (2015-2020)
Figure 38. Italy Plerixafor Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Plerixafor Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Plerixafor Revenue Market Share by Countries in 2019
Figure 41. China Plerixafor Revenue and Growth Rate (2015-2020)
Figure 42. Japan Plerixafor Revenue and Growth Rate (2015-2020)
Figure 43. Korea Plerixafor Revenue and Growth Rate (2015-2020)
Figure 44. India Plerixafor Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Plerixafor Revenue and Growth Rate (2015-2020)
Figure 46. South America Plerixafor Revenue Market Share by Countries (2015-2020)
Figure 47. South America Plerixafor Revenue Market Share by Countries in 2019
Figure 48. Brazil Plerixafor Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Plerixafor Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Plerixafor Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Plerixafor Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Plerixafor Revenue and Growth Rate (2015-2020)
Figure 53. UAE Plerixafor Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Plerixafor Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Plerixafor Revenue and Growth Rate (2015-2020)
Figure 56. Global Plerixafor Revenue Share by Type (2015-2020)
Figure 57. Global Plerixafor Revenue Share by Type in 2019
Figure 58. Global Plerixafor Market Share Forecast by Type (2021-2025)
Figure 59. Global 24MG/1.2ML Revenue Growth Rate (2015-2020)
Figure 60. Global Type II Revenue Growth Rate (2015-2020)
Figure 61. Global Plerixafor Revenue Share by Application (2015-2020)
Figure 62. Global Plerixafor Revenue Share by Application in 2019
Figure 63. Global Plerixafor Market Share Forecast by Application (2021-2025)
Figure 64. Global Non-Hodgkin's lymphoma (NHL) Patients Revenue Growth Rate (2015-2020)
Figure 65. Global Multiple myeloma (MM) Patients Revenue Growth Rate (2015-2020)
Figure 66. Global Plerixafor Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Plerixafor Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Plerixafor Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Plerixafor Revenue Market Forecast (2021-2025)
Figure 70. Europe Plerixafor Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Plerixafor Revenue Market Forecast (2021-2025)
Figure 72. South America Plerixafor Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Plerixafor Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---